Country Reports — Market Intelligence by Geography

Markets NXT — A Montclaire & Stein Venture

A Century of Global Intelligence Behind Every Report

Markets NXT builds on a legacy dating to the early 1900s, when economists Edgar Montclaire and Johann Stein began advising enterprises across Europe and North America on industrial expansion and globalization. Over more than a century, Montclaire & Stein accumulated institutional knowledge spanning economic intelligence and market dynamics across geographies — forming the analytical foundation behind every report we publish today.

Why Country-Level Intelligence Matters

Global markets are not uniform. Regulatory environments, consumer behavior, industrial composition, and competitive dynamics differ significantly by country. Country-specific research helps businesses:

  • Accurately size and forecast a market within a defined geography
  • Understand local demand drivers, supply chains, and competition
  • Navigate country-specific regulatory and policy frameworks
  • Identify entry points, opportunities, and risk factors at a national level

What Our Country Reports Cover

Each report delivers institutional-grade intelligence across: market sizing and forecasting, industry segmentation, competitive landscape, regulatory environment, macroeconomic context, and strategic recommendations — all grounded in conservative, multi-source validated methodology.

Institutional Rigour at the Most Competitive Pricing

Markets NXT offers country-specific research at the most competitive pricing in the industry, without compromising analytical standards. Our reports serve growth-stage businesses, investment firms, and consulting teams that need board-level intelligence without enterprise-level costs.

Explore Reports by Country

Browse and filter below to find market research reports for the country of your interest. Coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Showing 221 - 230 of 344 reports

U.S. Surgical Site Infection Control Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 3.8 Billion Market Size 2032: USD 6.4 Billion CAGR: 6.7% Market Definition: The U.S. surgical site infection (SSI) control market encompasses products, technologies, and services used to prevent, diagnose, and manage infections at surgical incision sites, including antimicrobial wound … Read More
Published October 2026

U.S. 3D Bioprinting Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: 3D Bioprinting Market Size 2024: USD 1.8 Billion Market Size 2032: USD 7.4 Billion CAGR: 19.4% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Organovo's Pivot Signals Maturity: Organovo's exit from commercial tissue printing … Read More
Published October 2026

U.S. Light Therapy Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 412.6 Million Market Size 2032: USD 891.4 Million CAGR: 10.1% Market Definition: The U.S. light therapy market encompasses devices and systems using specific wavelengths of light — including UV, red, near-infrared, and blue light — to treat conditions such … Read More
Published October 2026

U.S. Medical Holography Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 412.6 Million Market Size 2032: USD 1,387.4 Million CAGR: 16.4% Market Definition: The U.S. medical holography market encompasses holographic imaging technologies, display systems, and software platforms applied to clinical diagnosis, surgical planning, medical education, and pharmaceutical research across healthcare … Read More
Published October 2026

U.S. Neurology Devices Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Neurology Devices Market Size 2024: USD 10.4 Billion Market Size 2032: USD 18.7 Billion CAGR: 7.6% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Neuromodulation Drives Disproportionate Revenue: Medtronic's deep brain stimulation (DBS) segment … Read More
Published October 2026

U.S. Pharmaceutical Contract Manufacturing Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 28.4 billion Market Size 2032: USD 54.7 billion CAGR: 8.6% Market Definition: The U.S. pharmaceutical contract manufacturing market encompasses third-party manufacturing services for drug substances and drug products, including API synthesis, sterile fill-finish, oral solid dose production, and biologics … Read More
Published October 2026

U.S. Potassium Citrate Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 187.4 Million Market Size 2032: USD 298.6 Million CAGR: 6.0% Market Definition: The U.S. potassium citrate market encompasses the production, import, distribution, and end-use consumption of potassium citrate as a pharmaceutical ingredient, food additive, and dietary supplement across domestic … Read More
Published October 2026

U.S. Recombinant Proteins Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Recombinant Proteins Market Market Size 2024: USD 3.8 Billion Market Size 2032: USD 7.6 Billion CAGR: 9.1% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — CHO Cell Dominance Shifting: Chinese hamster ovary (CHO) cell-based … Read More
Published October 2026

U.S. Thyroid Disorder Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Thyroid Disorder Market Market Size 2024: USD 4.2 Billion Market Size 2032: USD 6.9 Billion CAGR: 6.4% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Levothyroxine Dominance Understated: AbbVie's Synthroid and generic levothyroxine collectively … Read More
Published October 2026

U.S. Cardiomyopathy Medication Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Cardiomyopathy Medication Market Size 2024: $4.2 billion Market Size 2032: $8.9 billion CAGR: 9.8% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Bristol Myers Squibb Dominates: Bristol Myers Squibb's mavacamten (Camzyos), approved in 2022, … Read More
Published October 2026